• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

8NE1:GR

2.511 EUR 0.158 5.92%

As of 15:16:13 ET on 12/23/2014.

Snapshot for NeoStem Inc (8NE1)

Open: 2.612 Day's Range: 2.511 - 2.734 Volume: 0
Previous Close: 2.669 52wk Range: 2.429 - 6.022 1-Yr Rtn: -45.68%

Stock Chart for 8NE1

No chart data available.
  • 8NE1:GR 2.698
  • 1D
  • 1M
  • 1Y
2.669
Interactive 8NE1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 8NE1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.7750
Est. PEG Ratio -
Market Cap (M EUR) 89.74
Shares Outstanding (M) 35.74
30 Day Average Volume 711
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 8NE1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 8NE1

NeoStem, Inc. develops and manufactures cell therapies. The Company through its subsidiaries offers contract manufacturing services and is developing a cell therapy for the treatment of cardiovascular disease.

Robin L SmithChief Executive OfficerRobert Dickey IVChief Financial Officer
Andrew L PecoraChief Visionary OfficerDouglas W LosordoChief Medical Officer
More Company Profile & Key Executives for 8NE1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil